New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2013
19:35 EDTCICigna shares could climb 20%, Barron's says
Cigna, which is up more than 50% in the past 12 months, may climb another 20% if it trades closer to 12 times earnings, which it has done in the past, says Barron's Weekday Trader. The report cites Don Wordell, manager of the RidgeWorth Mid-Cap Value Equity fund, who says Cigna's story gets better and better as the company shores up its balance sheet with smart acquisitions and the divestiture of non-core businesses. Reference Link
News For CI From The Last 14 Days
Check below for free stories on CI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
06:32 EDTCIPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use